Document Detail

Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease.
MedLine Citation:
PMID:  15864343     Owner:  NLM     Status:  MEDLINE    
Nonalcoholic fatty liver disease (NAFLD) is a component of the metabolic syndrome, with a clinical spectrum ranging from simple fatty liver to steatohepatitis, cirrhosis, and hepatocellular carcinoma. The primary event of NAFLD is the accumulation of triacylglycerols (TAGs) in hepatocytes. In this issue of the JCI, Donnelly et al. report on their use of stable isotope methodology to show that fatty acids stored in adipose tissue and fatty acids newly made within the liver through de novo lipogenesis are the major sources of TAGs in the liver and are secreted as lipoproteins in NAFLD.
Shinji Tamura; Iichiro Shimomura
Related Documents :
21395403 - Lipid peroxidation of poly-unsaturated fatty acids in normal and obese adipose tissues.
2933493 - Effect of dietary orotic acid on the levels of liver and blood nad in rats.
10190193 - Additional information to the in vitro antioxidant activity of ginkgo biloba l.
Publication Detail:
Type:  Comment; Journal Article    
Journal Detail:
Title:  The Journal of clinical investigation     Volume:  115     ISSN:  0021-9738     ISO Abbreviation:  J. Clin. Invest.     Publication Date:  2005 May 
Date Detail:
Created Date:  2005-05-02     Completed Date:  2005-07-12     Revised Date:  2013-06-09    
Medline Journal Info:
Nlm Unique ID:  7802877     Medline TA:  J Clin Invest     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1139-42     Citation Subset:  AIM; IM    
Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Suita, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adipose Tissue / metabolism*
Fatty Acids, Nonesterified / blood
Fatty Liver / metabolism*
Hepatocytes / metabolism
Lipids / biosynthesis*
Triglycerides / metabolism
Reg. No./Substance:
0/Fatty Acids, Nonesterified; 0/Lipids; 0/Triglycerides
Comment On:
J Clin Invest. 2005 May;115(5):1343-51   [PMID:  15864352 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The role of hepatic insulin receptors in the regulation of glucose production.
Next Document:  Caffey disease: an unlikely collagenopathy.